Recall Alert: 13K+ Bottles of Chlorthalidone Blood Pressure Medication Recalled Nationwide

More than 13,500 bottles of a common blood pressure medication, chlorthalidone tablets, have been recalled nationwide. The Food and Drug Administration (FDA) announced the recall of the medication, manufactured by Inventia Healthcare Limited, due to a failure in dissolution specifications.

The recall specifically targets 25mg doses of chlorthalidone tablets, packaged in 100-count bottles. These bottles carry the NDC number 64980-599-01, batch number RISA24002, and an expiration date of April 2027. The medication was distributed across the country.

The FDA initially issued the recall on September 3, and on September 17, it classified the action as a Class II recall. A Class II recall indicates that exposure to the product may cause temporary or medically reversible adverse health consequences, or that the probability of serious adverse health consequences is remote. This means while the issue is not immediately life-threatening, it warrants attention from those using the medication.

Chlorthalidone serves as a diuretic, or water pill, and doctors prescribe it to treat high blood pressure. The Mayo Clinic also notes its use in managing fluid retention caused by conditions such as congestive heart failure, severe liver disease, or kidney disease. This is not the first time chlorthalidone has faced a recall; in June, a similar medication distributed by Rising Pharma Holdings was also recalled for failing dissolution specifications.